The Patent Finder

Hummingbird Diagnostics GmbH

16 patents currently held · Updated Nov 16, 2026
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
4
Ending by 2030
Jun 2030
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Apr 1, 2027
    The maintenance fee for MiRNA based treatment monitoring in multiple sclerosis (US 10,428,382) comes due Apr 1, 2027. Unpaid by Oct 1, 2027, it lapses early.
  • 2 fees due May 17 to 24, 2027 · next May 17
  • 1 fee due Aug 2, 2027
    The maintenance fee for Complex sets of miRNAs as non-invasive biomarkers for colon cancer (US 9,249,469) comes due Aug 2, 2027. Unpaid by Feb 2, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
PatentTitleStatus Expires Confidence
US 9,702,008miRNA fingerprint in the diagnosis of diseases
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,758,827miRNA fingerprint in the diagnosis of lung cancer
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,528,158miRNA fingerprint in the diagnosis of COPD
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,745,630MiRNA fingerprint in the diagnosis of prostate cancer
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,822,416miRNA in the diagnosis of ovarian cancer
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,611,511Complex miRNA sets as novel biomarkers for an acute coronary syndrome
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,187,785miRNA fingerprint in the diagnosis of multiple sclerosis
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,194,002miRNA fingerprint in the diagnosis of diseases
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,718,018Complex sets of miRNAs as non-invasive biomarkers for dilated cardiomyopathy
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,249,469Complex sets of miRNAs as non-invasive biomarkers for colon cancer
In force
 · From the USPTO record
In forceFrom the USPTO record
10 of 16 patents shown.
Pro members see all 16.
Pro members: see all 16 patents
Also on record, not counted in the 16: 4 lapsed for an unpaid fee. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

2 pending · 7 no status recorded

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited